Progression of resectable pancreatic ductal adenocarcinoma during surgical delay and effects on survival – A propensity score matched study
Progression in tumor size does not seem to affect survival in our study population. In general, surgical treatment delay in up-front resectable patients does not seem to be associated with survival or the risk of recurrence, but the optimal and maximal time to surgery as well as the optimal timing of the follow-up scanning remain unclear.
Authors
- Carsten Palnæs Hansen (ORCID: https://orcid.org/0000-0002-9256-2240)
- Luit Penninga (ORCID: https://orcid.org/0000-0002-8531-1865)
- Thomas Skårup Kristensen (ORCID: https://orcid.org/0000-0002-7305-0880)
- Bojan Kovacevic (ORCID: https://orcid.org/0000-0003-3941-0544)
- Caroline Ewertsen
Institutions
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
Publication Details
- Journal
- Pancreatology
- Published
- 2024-11-23
- DOI
- https://doi.org/10.1016/j.pan.2024.11.015
- Citations
- 3
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- Region Hovedstaden